Capricor Therapeutics, Inc. (CAPR)
9.92
+0.33
(+3.44%)
USD |
NASDAQ |
Aug 31, 16:00
9.89
-0.03
(-0.30%)
After-Hours: 20:00
Capricor Therapeutics Cash from Operations (TTM) : -104.00M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -104.00M |
| March 31, 2026 | -92.63M |
| December 31, 2025 | -69.81M |
| September 30, 2025 | -61.04M |
| June 30, 2025 | -52.99M |
| March 31, 2025 | -45.16M |
| December 31, 2024 | -40.00M |
| September 30, 2024 | -36.79M |
| June 30, 2024 | -33.95M |
| March 31, 2024 | -31.08M |
| December 31, 2023 | -25.60M |
| September 30, 2023 | -20.90M |
| June 30, 2023 | -17.80M |
| March 31, 2023 | -14.92M |
| December 31, 2022 | 4.917M |
| September 30, 2022 | 6.191M |
| June 30, 2022 | 8.539M |
| March 31, 2022 | 10.57M |
| December 31, 2021 | -16.81M |
| September 30, 2021 | -15.02M |
| June 30, 2021 | -14.66M |
| March 31, 2021 | -12.17M |
| December 31, 2020 | -10.05M |
| September 30, 2020 | -7.997M |
| June 30, 2020 | -6.671M |
| Date | Value |
|---|---|
| March 31, 2020 | -6.432M |
| December 31, 2019 | -6.822M |
| September 30, 2019 | -8.808M |
| June 30, 2019 | -10.14M |
| March 31, 2019 | -12.05M |
| December 31, 2018 | -13.86M |
| September 30, 2018 | -12.76M |
| June 30, 2018 | -12.97M |
| March 31, 2018 | -12.97M |
| December 31, 2017 | -14.23M |
| September 30, 2017 | -16.14M |
| June 30, 2017 | -16.86M |
| March 31, 2017 | -18.05M |
| December 31, 2016 | -17.55M |
| September 30, 2016 | -16.62M |
| June 30, 2016 | -16.55M |
| March 31, 2016 | -14.99M |
| December 31, 2015 | -13.79M |
| September 30, 2015 | -13.02M |
| June 30, 2015 | -12.08M |
| March 31, 2015 | -10.94M |
| December 31, 2014 | 2.534M |
| September 30, 2014 | 1.019M |
| June 30, 2014 | 3.761M |
| March 31, 2014 | 5.898M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| REGENXBIO, Inc. | -246.67M |
| Cytokinetics, Inc. | -555.45M |
| Emergent BioSolutions, Inc. | 97.70M |
| Rigel Pharmaceuticals, Inc. | 79.39M |
| United Therapeutics Corp. | 1.682B |